Pulmonary Arterial Hypertension and Specialty Care Centers: We Had a Feeling; Now We Have Data

Murali M. Chakinala; Harrison W. Farber

doi:10.1016/j.chest.2020.03.079

Pulmonary Arterial Hypertension and Specialty Care Centers: We Had a Feeling; Now We Have Data

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	28-30
Number of pages	3
Journal	CHEST
Volume	158
Issue number	1
DOIs	https://doi.org/10.1016/j.chest.2020.03.079
State	Published - Jul 2020

Access to Document

10.1016/j.chest.2020.03.079

Cite this

@article{282617706f424d55ada0e7f1db3a5a34,

title = "Pulmonary Arterial Hypertension and Specialty Care Centers: We Had a Feeling; Now We Have Data",

author = "Chakinala, {Murali M.} and Farber, {Harrison W.}",

note = "Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: M. M. C. discloses research support to his institution from Actelion, Bayer, Medtronic, United Therapeutics, Reata, Liquidia, Altavant, Complexa, Acceleron, and Phase Bio; consulting or advisory boards for Actelion, Arena, Bayer, Acceleron, Phase Bio, Express Scripts, and Trio Health Analytics; and serving on a speakers bureau for Bayer. H. W. F. discloses research support to his institution from Actelion, United Therapeutics, Altavant, Complexa, Acceleron, and Phase Bio; consulting or advisory boards for Actelion, Acceleron, United Therapeutics, Altavant, and Trio Health Analytics; and a speakers bureau for Bayer.",

year = "2020",

month = jul,

doi = "10.1016/j.chest.2020.03.079",

language = "English",

volume = "158",

pages = "28--30",

journal = "CHEST",

issn = "0012-3692",

number = "1",

}

TY - JOUR

T1 - Pulmonary Arterial Hypertension and Specialty Care Centers

T2 - We Had a Feeling; Now We Have Data

AU - Chakinala, Murali M.

AU - Farber, Harrison W.

N1 - Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: M. M. C. discloses research support to his institution from Actelion, Bayer, Medtronic, United Therapeutics, Reata, Liquidia, Altavant, Complexa, Acceleron, and Phase Bio; consulting or advisory boards for Actelion, Arena, Bayer, Acceleron, Phase Bio, Express Scripts, and Trio Health Analytics; and serving on a speakers bureau for Bayer. H. W. F. discloses research support to his institution from Actelion, United Therapeutics, Altavant, Complexa, Acceleron, and Phase Bio; consulting or advisory boards for Actelion, Acceleron, United Therapeutics, Altavant, and Trio Health Analytics; and a speakers bureau for Bayer.

PY - 2020/7

Y1 - 2020/7

UR - http://www.scopus.com/inward/record.url?scp=85086999660&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2020.03.079

DO - 10.1016/j.chest.2020.03.079

M3 - Editorial

C2 - 32654707

AN - SCOPUS:85086999660

SN - 0012-3692

VL - 158

SP - 28

EP - 30

JO - CHEST

JF - CHEST

IS - 1

ER -

Pulmonary Arterial Hypertension and Specialty Care Centers: We Had a Feeling; Now We Have Data

Access to Document

Other files and links

Cite this